{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:18Z","timestamp":1794047478963,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"12","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2024.285562","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T11:25:41Z","timestamp":1723116341000},"page":"4120-4124","source":"Crossref","is-referenced-by-count":0,"title":["An important oversight in the World Health Organization diagnostic classification: chronic myeloid leukemia with the &lt;i&gt;PML::RARA&lt;\/i&gt; fusion clone"],"prefix":"10.3324","volume":"109","author":[{"given":"Jieyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoquan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"70294","doi-asserted-by":"crossref","unstructured":"Shi Y, Rand AJ, Crow JH, Moore JO, Lagoo AS. Blast phase in chronic myelogenous leukemia is skewed toward unusual blast types in patients treated with tyrosine kinase inhibitors: a comparative study of 67 cases. Am J Clin Pathol. 2015; 143(1):105-119.","DOI":"10.1309\/AJCPWEX5YY4PHSCN"},{"key":"70295","doi-asserted-by":"crossref","unstructured":"Wolanin S, McCall RK, Pettenati MJ. PML-RARA fusion transcripts detectable 8 months prior to promyelocytic blast crisis in chronic myeloid leukemia. Case Rep Hematol. 2020; 2020:8830595.","DOI":"10.1155\/2020\/8830595"},{"key":"70296","doi-asserted-by":"crossref","unstructured":"Emilia G, Sacchi S, Selleri L, Zucchini P, Artusi T, Torelli U. Promyelocytic crisis of chronic myeloid leukaemia. Br J Haematol. 1987; 66(2):276-277.","DOI":"10.1111\/j.1365-2141.1987.tb01313.x"},{"key":"70297","doi-asserted-by":"crossref","unstructured":"Van der Merwe T, Bernstein R, Derman D. Acute promyelocytic transformation of chronic myeloid leukaemia with an isochromosome 17q. Br J Haematol. 1986; 64(4):751-756.","DOI":"10.1111\/j.1365-2141.1986.tb02237.x"},{"key":"70298","doi-asserted-by":"crossref","unstructured":"Ben-Zeev D, Schwartz SO, Friedman IA. Promyelocytic-myelocytic leukemia as a terminal manifestation of chronic granulocytic leukemia. Report of a case. Blood. 1966; 27(6):863-870.","DOI":"10.1182\/blood.V27.6.863.863"},{"key":"70299","doi-asserted-by":"crossref","unstructured":"Kim B, Chi HY, Yoon YA, Choi YJ. Promyelocytic blast phase of chronic myeloid leukemia, BCR-ABL1-positive: points to be considered at diagnosis. Ann Lab Med. 2021; 41(3):328-332.","DOI":"10.3343\/alm.2021.41.3.328"},{"key":"70300","doi-asserted-by":"crossref","unstructured":"Parsi M, Budak-Alpdogan T. Promyelocytic blast crisis of chronic myeloid leukemia in a patient undergoing therapy with a tyrosine kinase inhibitor. Cureus. 2020; 12(3):e7217.","DOI":"10.7759\/cureus.7217"},{"key":"70301","unstructured":"Liu MS, Han XY, Qu ZG. Rapid promyelocytic blast crisis of chronic myeloid leukemia with PML-RAR\u03b1 fusion gene: a case report and literature review. Zhonghua Xue Ye Xue Za Zhi. 2023; 44(6):512-515."},{"key":"70302","doi-asserted-by":"crossref","unstructured":"Cai B, Yang W, Zhao Y. Successful management with an effective induction regimen followed by allogeneic hematopoietic stem cell transplantation for promyelocytic blast crisis of chronic myelogenous leukemia. Ann Hematol. 2012; 91(4):621-623.","DOI":"10.1007\/s00277-011-1269-1"},{"key":"70303","doi-asserted-by":"crossref","unstructured":"Kashimura M, Ohyashiki K. Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia. Leuk Res. 2010; 34(8):e213-214.","DOI":"10.1016\/j.leukres.2010.02.030"},{"key":"70304","doi-asserted-by":"crossref","unstructured":"Bavaro L, Martelli M, Cavo M, Soverini S. Mechanisms of disease progression and resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update. Int J Mol Sci. 2019; 20(24):6141.","DOI":"10.3390\/ijms20246141"},{"key":"70305","doi-asserted-by":"crossref","unstructured":"Ito K, Bernardi R, Morotti A. PML targeting eradicates quiescent leukaemia-initiating cells. Nature. 2008; 453(7198):1072-1078.","DOI":"10.1038\/nature07016"},{"key":"70306","doi-asserted-by":"crossref","unstructured":"Daniel MT, Koken M, Romagn\u00e9 O. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood. 1993; 82(6):1858-1867.","DOI":"10.1182\/blood.V82.6.1858.bloodjournal8261858"},{"key":"70307","doi-asserted-by":"crossref","unstructured":"Khoury JD, Solary E, Abla O. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022; 36(7):1703-1719.","DOI":"10.1038\/s41375-022-01613-1"},{"key":"70308","doi-asserted-by":"crossref","unstructured":"Arber DA, Orazi A, Hasserjian RP. International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022; 140(11):1200-1228.","DOI":"10.1182\/blood.2022015850"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285562\/77464","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285562\/77851","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11720\/77464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:07Z","timestamp":1794046027000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285562","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}